CMS proposes lifting restrictions on NGS cancer testing

In a new draft national coverage determination published Tuesday, CMS proposed extending coverage of next generation sequencing tests to earlier-stage cancers and patients whose genetics may put them at risk for developing cancer. Those changes reflect concerns raised by the healthcare industry earlier this year related to a March 2018 draft.